{"id":3827,"date":"2017-08-12T18:58:11","date_gmt":"2017-08-12T18:58:11","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/deep-local-hyperthermia-meht\/"},"modified":"2026-02-11T08:31:05","modified_gmt":"2026-02-11T08:31:05","slug":"moduleeritud-rf-hupertermia","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/et\/moduleeritud-rf-hupertermia\/","title":{"rendered":"Moduleeritud RF-h\u00fcpertermia (13,56 MHz RF mHT + RF-spetsiifiline patoloogia)"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"Article\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/moduleeritud-rf-hupertermia\/#article\",\n      \"mainEntityOfPage\": {\n        \"@type\": \"WebPage\",\n        \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/moduleeritud-rf-hupertermia\/#webpage\"\n      },\n      \"headline\": \"Moduleeritud raadiosageduslik h\u00fcpertermia - 13,56 MHz mHT\",\n      \"description\": \"Moduleeritud raadiosageduslik h\u00fcpertermia (mHT) on tipptasemel soojusravi, mis sihib ja h\u00e4vitab selektiivselt pahaloomulisi rakke, kahjustamata terveid kudesid. See uusima p\u00f5lvkonna meditsiiniline innovatsioon edastab t\u00e4pset, kontrollitud ja s\u00fcgavat energiat (kombineerides h\u00fcpertermilist ja elektromagnetilist m\u00f5ju), kasutades 13,56 MHz amplituudmoduleeritud raadiosagedust, et suurendada keemia-, kiiritus- ja immuunravi efektiivsust ning parandada patsientide elukvaliteeti.\",\n      \"image\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/07\/modulated-RF-HT-selective-cancer-cells-300x213.jpg\",\n        \"width\": 300,\n        \"height\": 213,\n        \"caption\": \"Moduleeritud RF HT selektiivne v\u00e4hirakkude sihtimine\"\n      },\n      \"datePublished\": \"2025-07-28T00:00:00+02:00\",\n      \"dateModified\": \"2026-02-11T10:00:00+02:00\",\n      \"author\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"publisher\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"keywords\": [\n        \"Moduleeritud raadiosageduslik h\u00fcpertermia\", \"mHT\", \"13.56 MHz\", \"selektiivne v\u00e4hiravi\", \"onkoloogiline h\u00fcpertermia\", \"Andromedic HyDeep 600WM\", \"imunogeenne rakusurm\", \"abskopaalne efekt\"\n      ],\n      \"about\": [\n        {\n          \"@type\": \"MedicalTherapy\",\n          \"name\": \"Moduleeritud RF-h\u00fcpertermia\",\n          \"alternateName\": [\"mHT\", \"RF h\u00fcpertermia\", \"h\u00fcpertermia teraapia\"]\n        },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/sugav-lokaalne-hupertermia-seade\/#product\" },\n        {\n          \"@type\": \"MedicalCondition\",\n          \"name\": \"V\u00e4hk\",\n          \"alternateName\": [\"Pahaloomulised rakud\", \"Kasvajad\", \"Onkoloogilised patoloogiad\"]\n        }\n      ],\n      \"mentions\": [\n        { \"@type\": \"Thing\", \"name\": \"13.56 MHz\" },\n        { \"@type\": \"Thing\", \"name\": \"RF modulatsioon\" },\n        { \"@type\": \"Thing\", \"name\": \"Elektromagnetilised m\u00f5jud\" },\n        { \"@type\": \"Thing\", \"name\": \"Imunogeenne rakusurm\", \"alternateName\": \"ICD\" },\n        { \"@type\": \"Thing\", \"name\": \"Abskopaalne efekt\" },\n        { \"@type\": \"Thing\", \"name\": \"Elukvaliteet\", \"alternateName\": \"QoL\" }\n      ],\n      \"citation\": [\n        \"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5356646\/\",\n        \"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4569\"\n      ]\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/sugav-lokaalne-hupertermia-seade\/#product\",\n      \"name\": \"Andromedic HyDeep 600WM\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/et\/sugav-lokaalne-hupertermia-seade\/\",\n      \"description\": \"HyDeep 600 WM on t\u00e4iustatud onkoloogilise h\u00fcpertermia s\u00fcsteem\/seade, s\u00fcgav lokaalne h\u00fcpertermia s\u00fcsteem\/seade ja moduleeritud raadiosagedusliku (RF) h\u00fcpertermia s\u00fcsteem\/seade, elektro-h\u00fcpertermia s\u00fcsteem\/seade. Sertifitseeritud CE, ISO 13485, MDR.\",\n      \"brand\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#brand\" },\n      \"manufacturer\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"aggregateRating\": {\n        \"@type\": \"AggregateRating\",\n        \"ratingValue\": \"4.9\",\n        \"reviewCount\": \"40\"\n      }\n    },\n    {\n      \"@type\": \"WebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/moduleeritud-rf-hupertermia\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/et\/moduleeritud-rf-hupertermia\/\",\n      \"name\": \"Moduleeritud RF-h\u00fcpertermia (mHT) - Andromedic Hyperthermia\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"inLanguage\": \"et\",\n      \"breadcrumb\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/moduleeritud-rf-hupertermia\/#breadcrumb\" }\n    },\n    {\n      \"@type\": \"BreadcrumbList\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/moduleeritud-rf-hupertermia\/#breadcrumb\",\n      \"itemListElement\": [\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 1,\n          \"item\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/\", \"name\": \"Avaleht\" }\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 2,\n          \"item\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/moduleeritud-rf-hupertermia\/\", \"name\": \"Moduleeritud RF-h\u00fcpertermia\" }\n        }\n      ]\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Hyperthermia\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/et\/\",\n      \"logo\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/logo.png\"\n      }\n    }\n  ]\n}\n<\/script><\/p>\n<div class=\"mht-clinical-container\" style=\"max-width: 1100px; margin: 0 auto; font-family: 'Segoe UI', Roboto, Helvetica, Arial, sans-serif; color: #2c3e50; line-height: 1.7;\">\n<header style=\"border-bottom: 3px solid #004a99; margin-bottom: 30px; padding-bottom: 20px;\">\n<h1 style=\"color: #004a99; font-size: 2.4em; margin-bottom: 10px;\">Moduleeritud RF-h\u00fcpertermia \u2013 13,56 MHz mHT tehnoloogia<\/h1>\n<p style=\"font-size: 1.15em; font-weight: 400;\">Moduleeritud RF-h\u00fcpertermia (mHT) on t\u00e4iustatud soojusravi, mis kasutab <strong>s\u00fcnergilist termilist ja mittetermilist (elektromagnetilist) toimet<\/strong>, et h\u00e4vitada pahaloomulisi rakke <strong>SELEKTIIVSELT<\/strong>, kahjustamata terveid rakke.<\/p>\n<\/header>\n<div style=\"display: flex; flex-wrap: wrap; gap: 40px; margin-bottom: 50px; align-items: flex-start;\">\n<div style=\"flex: 1; min-width: 320px;\">\n<p>mHT on uusima p\u00f5lvkonna meditsiiniline innovatsioon, mis edastab v\u00e4hirakkudesse <strong>selektiivset, kontrollitud ja s\u00fcvatoimelist energiat (h\u00fcpertermiline + elektromagnetiline)<\/strong>, kasutades mahtuvuslikult sidestatud 13,56 MHz amplituudmoduleeritud raadiosagedust.<\/p>\n<div style=\"background: #f0f7ff; border-left: 5px solid #004a99; padding: 20px; margin: 20px 0;\">\n<h2 style=\"margin-top: 0; color: #004a99; font-size: 1.3em;\">\u00dclim s\u00fcvatoime onkoloogias<\/h2>\n<p>Kahe elektroodiga 13,56 MHz mHT suudab tungida kuni <strong>38,4 cm s\u00fcgavusele<\/strong> ning on uuringutes osutunud t\u00f5husamaks kui 8 MHz cCHT<br \/>\n<a style=\"color: #004a99; text-decoration: underline;\" title=\"13,56 MHz ja 8 MHz h\u00fcpertermia v\u00f5rdlev uuring\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5356646\/\" target=\"_blank\" rel=\"noopener\">(Viide)<\/a>.<\/p>\n<\/div>\n<p>mHT edastab soojusenergiat ainult kasvajaraki membraanile ja ekstratsellulaarsele maatriksile, kasutades temperatuure alla 43 \u00b0C, lahendades traditsioonilise h\u00fcpertermia piirangud <strong>rakul\u00e4hedasel tasandil<\/strong>.<\/p>\n<\/div>\n<div style=\"flex: 1; min-width: 320px; text-align: center;\">\n<figure style=\"margin: 0; background: #fff; padding: 15px; border: 1px solid #e1e8ed; border-radius: 8px; box-shadow: 0 4px 12px rgba(0,0,0,0.08);\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 4px;\" title=\"mHT selektiivne mehhanism\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/07\/modulated-RF-HT-selective-cancer-cells-300x213.jpg\" alt=\"Moduleeritud RF-h\u00fcpertermia mHT selektiivne toime v\u00e4hirakkudele\" \/><figcaption style=\"font-size: 0.9em; text-align: left; padding-top: 15px; line-height: 1.4; color: #576574;\"><strong>Joonis 1. mHT selektiivne mehhanism.<\/strong> Moduleeritud raadiosageduslik vool liigub peamiselt ekstratsellulaarsesse elektrol\u00fc\u00fcti, kuna normaalsed rakud on elektrooniliselt isoleeritud enam kui miljoni V\/m elektriv\u00e4lja tugevusega <em>(Hegyi G, Szasz O, Szasz A. PMID: 24494322.)<\/em><\/figcaption><\/figure>\n<\/div>\n<\/div>\n<h2 style=\"color: #004a99; text-align: center; margin-bottom: 35px;\">Amplituudmoduleeritud RF-h\u00fcpertermia kliinilised eelised<\/h2>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(320px, 1fr)); gap: 25px; margin-bottom: 50px;\">\n<div style=\"background: #fff; border: 1px solid #e1e8ed; border-top: 4px solid #004a99; padding: 25px; border-radius: 0 0 8px 8px;\">\n<h3 style=\"margin-top: 0; color: #004a99; font-size: 1.2em;\">Keemiaravi ja bioloogiline tugi<\/h3>\n<p style=\"font-size: 0.95em;\"><strong>Parem perfusioon:<\/strong> T\u00e4nu vasodilatatsiooni efektile tagab mHT keemiaravi v\u00f5i bioloogiliste ainete parema kohaletoimetamise <a title=\"Kosin Medical Journal: H\u00fcpertermia tulemused\" href=\"https:\/\/www.kosinmedj.org\/journal\/view.php?number=1294\" target=\"_blank\" rel=\"noopener\">(viide)<\/a>, parandades ravitulemusi.<\/p>\n<\/div>\n<div style=\"background: #fff; border: 1px solid #e1e8ed; border-top: 4px solid #004a99; padding: 25px; border-radius: 0 0 8px 8px;\">\n<h3 style=\"margin-top: 0; color: #004a99; font-size: 1.2em;\">Radiosenzitiseerimine<\/h3>\n<p style=\"font-size: 0.95em;\">Kasvaja ja \u00fcmbritsevate kudede <strong>oksigenatsiooni<\/strong> muutused teevad mHT-st suurep\u00e4rase valiku enne ja p\u00e4rast kiiritusravi, muutes kasvaja kiirguse suhtes tundlikumaks <a title=\"Uuring radiosenzitiseerimise ja mHT kohta\" href=\"https:\/\/www.kosinmedj.org\/journal\/view.php?number=1294\" target=\"_blank\" rel=\"noopener\">(viide)<\/a>.<\/p>\n<\/div>\n<div style=\"background: #fdf2f2; border: 1px solid #f8d7da; border-top: 4px solid #d9534f; padding: 25px; border-radius: 0 0 8px 8px;\">\n<h3 style=\"margin-top: 0; color: #c0392b; font-size: 1.2em;\">Immunogeensed toimed (Abscopal)<\/h3>\n<p style=\"font-size: 0.9em; line-height: 1.5;\"><strong>ICD indutseerija:<\/strong> mHT moduleerib kasvaja mikrokeskkonda (TME), k\u00e4ivitades <strong>DAMP<\/strong> ja <strong>HSP70<\/strong> vabanemise. See aktiveerib NK-rakke ja k\u00fcpsetab dendriitrakke (DC), tekitades s\u00fcsteemse vastuse kaugetele metastaasidele.<\/p>\n<div style=\"font-family: monospace; font-size: 0.85em; background: #fff; padding: 10px; border-radius: 4px; border: 1px dashed #d9534f; margin-top: 10px;\">mHT (ICD indutseerija) -&gt; DAMP -&gt; HSP70 -&gt; DC -&gt; T-rakud (CTL, Th1, Tmemory) -&gt; <strong>S\u00fcsteemne kasvajavastane vastus<\/strong><\/div>\n<p style=\"font-size: 0.85em; margin-top: 10px; color: #7f8c8d;\">Ralph Kleef jt uuringud on n\u00e4idanud paremust nivolumabi ja ipilimumabi ees seedetrakti v\u00e4hivormide puhul <a title=\"Ralph Kleefi uuring mHT ja immunoteraapia kohta\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10663566\/\" target=\"_blank\" rel=\"noopener\">(viide)<\/a>.<\/p>\n<\/div>\n<\/div>\n<div style=\"background: #f8fbff; padding: 30px; border-radius: 12px; border: 1px solid #e1e8ed; margin-bottom: 50px;\">\n<h3 style=\"color: #004a99; margin-top: 0;\">Kliinilised tulemused: \u00dcldine elulemus (OS) ja elukvaliteet<\/h3>\n<p>mHT lisamine on korduvalt n\u00e4idanud <strong>\u00fcldise elulemuse (OS) pikenemist<\/strong>, kasvaja lokaalset kontrolli ja <strong>elukvaliteedi (QoL) paranemist<\/strong> <a title=\"Kliinilised t\u00f5endid OS ja QoL kohta koos mHT-ga\" href=\"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4569\" target=\"_blank\" rel=\"noopener\">(viide)<\/a>.<\/p>\n<p style=\"font-style: italic; font-size: 0.95em; color: #576574;\">Toetav adjuvantne, neoadjuvantne ja palliatiivne ravi neoplastiliste patoloogiate, infektsioonide, p\u00f5letike ja valu korral.<\/p>\n<\/div>\n<section style=\"background: linear-gradient(135deg, #004a99 0%, #002d5d 100%); color: #fff; padding: 40px; border-radius: 15px; text-align: center; box-shadow: 0 10px 20px rgba(0,74,153,0.2);\">\n<h2 style=\"color: #fff; margin-top: 0; font-size: 1.8em;\">T\u00e4iustatud mHT: Andromedic HyDeep 600WM<\/h2>\n<p style=\"font-size: 1.1em; max-width: 800px; margin: 0 auto 25px auto;\">Andromedicu <strong>moduleeritud onkoloogilise h\u00fcpertermia seade<\/strong> kasutab kandjasagedusena 13,56 MHz ja kombineerib selle <strong>igale patoloogiale ja v\u00e4hit\u00fc\u00fcbile spetsiifiliste raadiosagedustega<\/strong>, parandades oluliselt klassikalise mHT tulemusi.<\/p>\n<p><a style=\"display: inline-block; background: #ffd700; color: #002d5d; padding: 15px 35px; border-radius: 30px; text-decoration: none; font-weight: bold; font-size: 1.1em; transition: transform 0.2s;\" href=\"https:\/\/andromedichyperthermia.com\/et\/sugav-lokaalne-hupertermia-seade\/\"><br \/>\nTutvu HyDeep 600WM seadme tehnoloogiaga<br \/>\n<\/a><\/p>\n<\/section>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Moduleeritud RF-h\u00fcpertermia (mHT) on soojusravi, mis kasutab s\u00fcnergilist termilist ja mittetermilist (elektromagnetilist) toimet, et h\u00e4vitada pahaloomulisi rakke SELEKTIIVSELT, kahjustamata terveid rakke. mHT on uusima p\u00f5lvkonna meditsiiniline innovatsioon, mis edastab v\u00e4hirakkudesse selektiivset, kontrollitud ja s\u00fcvatoimelist energiat (h\u00fcpertermiline + elektromagnetiline), kasutades mahtuvuslikult sidestatud 13,56 MHz amplituudmoduleeritud raadiosagedust.<\/p>\n<p>Kahe elektroodiga 13,56 MHz mHT suudab tungida kuni 38,4 cm s\u00fcgavusele ning on uuringutes osutunud t\u00f5husamaks kui 8 MHz cCHT.<\/p>\n<p>Lisaks kasutab Andromedicu HyDeep 600 WM (s\u00fcva-lokaalse h\u00fcpertermia seade \/ elektro-h\u00fcpertermia seade) kandjasagedusena 13,56 MHz RF-i ning kombineerib selle igale patoloogiale ja v\u00e4hit\u00fc\u00fcbile spetsiifiliste raadiosagedustega, omades seel\u00e4bi potentsiaali parandada klassikalise 13,56 MHz mHT ravitulemusi.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3827","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages\/3827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/comments?post=3827"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages\/3827\/revisions"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/media?parent=3827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}